IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BONACINA, FABRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.206
NA - Nord America 6.190
EU - Europa 5.136
Continente sconosciuto - Info sul continente non disponibili 528
SA - Sud America 465
AF - Africa 157
OC - Oceania 60
Totale 18.742
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.841
CN - Cina 2.653
IT - Italia 1.962
SG - Singapore 1.206
DE - Germania 708
GB - Regno Unito 618
BD - Bangladesh 520
HK - Hong Kong 499
VN - Vietnam 350
BR - Brasile 337
SE - Svezia 319
RU - Federazione Russa 257
FR - Francia 251
CA - Canada 218
IN - India 218
JP - Giappone 185
NL - Olanda 185
FI - Finlandia 148
KR - Corea 114
ID - Indonesia 113
ES - Italia 105
IE - Irlanda 102
DK - Danimarca 99
TR - Turchia 80
MX - Messico 70
PL - Polonia 69
CH - Svizzera 56
AU - Australia 52
TW - Taiwan 50
CI - Costa d'Avorio 49
AT - Austria 46
AR - Argentina 33
IR - Iran 31
GR - Grecia 28
BE - Belgio 26
IQ - Iraq 26
RO - Romania 24
CO - Colombia 21
CR - Costa Rica 20
UA - Ucraina 20
TH - Thailandia 19
EC - Ecuador 18
CL - Cile 16
VE - Venezuela 16
ZA - Sudafrica 16
MY - Malesia 15
PH - Filippine 15
EG - Egitto 14
HU - Ungheria 14
IL - Israele 14
AE - Emirati Arabi Uniti 13
CZ - Repubblica Ceca 13
DZ - Algeria 13
PT - Portogallo 13
SA - Arabia Saudita 13
HR - Croazia 12
JM - Giamaica 11
LB - Libano 11
MA - Marocco 11
NO - Norvegia 11
PE - Perù 11
UZ - Uzbekistan 10
JO - Giordania 9
RE - Reunion 9
SC - Seychelles 9
NZ - Nuova Zelanda 8
BA - Bosnia-Erzegovina 7
HN - Honduras 7
PK - Pakistan 7
LU - Lussemburgo 6
NP - Nepal 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
TT - Trinidad e Tobago 6
AL - Albania 5
ET - Etiopia 5
KW - Kuwait 5
UY - Uruguay 5
XK - ???statistics.table.value.countryCode.XK??? 5
ZW - Zimbabwe 5
BO - Bolivia 4
GH - Ghana 4
KE - Kenya 4
KG - Kirghizistan 4
MO - Macao, regione amministrativa speciale della Cina 4
NI - Nicaragua 4
SI - Slovenia 4
SV - El Salvador 4
TN - Tunisia 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BJ - Benin 3
BY - Bielorussia 3
EE - Estonia 3
LV - Lettonia 3
NG - Nigeria 3
PR - Porto Rico 3
PY - Paraguay 3
BH - Bahrain 2
CY - Cipro 2
Totale 18.191
Salva come PNG Salva come JPEG
Città #
Singapore 718
Milan 683
Ashburn 611
Southend 415
Hong Kong 394
San Jose 381
Beijing 322
Council Bluffs 275
Santa Clara 266
Dallas 258
Frankfurt am Main 228
Fairfield 201
Shanghai 195
Guangzhou 192
Los Angeles 190
Chandler 185
Redwood City 184
New York 169
Hefei 158
Seattle 131
Hanover 119
Wilmington 118
Woodbridge 112
Ann Arbor 107
Rome 105
Hanoi 103
Houston 100
Nanjing 98
Helsinki 93
Dublin 91
Boardman 87
Cambridge 85
Jakarta 82
Ho Chi Minh City 79
Bengaluru 70
Princeton 70
Tokyo 69
Changsha 66
Dearborn 66
Buffalo 59
Tianjin 59
Lauterbourg 54
Wuhan 53
Hangzhou 52
Munich 52
The Dalles 51
Moscow 50
Abidjan 49
Phoenix 48
Jinan 47
Naples 45
Toronto 44
Seoul 42
Chicago 38
São Paulo 35
Montreal 34
Monza 34
Berlin 33
Chengdu 33
Warsaw 33
Magenta 32
Nuremberg 32
Shenyang 32
Atlanta 30
Turin 30
Chongqing 29
Columbus 29
Grafing 28
Istanbul 27
Cangzhou 26
Zhengzhou 25
Des Moines 24
Lappeenranta 24
Nanchang 23
Cinisello Balsamo 22
Madrid 22
Bari 21
Suzhou 21
Zurich 21
London 20
Paris 20
Barcelona 19
Brescia 19
Brussels 19
Hebei 19
Taipei 19
Bologna 18
Boston 18
Hillsboro 18
Palermo 18
San Francisco 18
Xi'an 18
Amsterdam 17
Da Nang 17
Philadelphia 17
Chennai 16
Fuzhou 16
Haiphong 16
Manchester 16
Mumbai 16
Totale 9.693
Salva come PNG Salva come JPEG
Nome #
PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor 2.566
The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis 939
Lysosomal Acid Lipase: From Cellular Lipid Handler to Immunometabolic Target 860
Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progression 764
Pentraxin 3 deficiency protects from the metabolic inflammation associated to diet-induced obesity 611
Fenretinide treatment accelerates atherosclerosis development in apoE-deficient mice in spite of beneficial metabolic effects 515
PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction 480
Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation 424
ROLE OF THE LONG PENTRAXIN 3 (PTX3) IN CARDIOMETABOLIC DISEASES 418
Cluster-assembled zirconia substrates promote long-term differentiation and functioning of human islets of Langerhans 372
Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis 321
Fatty acid metabolism complements glycolysis in th selective regulatory t cell expansion during tumor growth 320
Fenretinide treatment accelerates atherosclerosis development in apolipoprotein e-deficient mice in spite of beneficial metabolic effects 296
The low-density lipoprotein receptor-mTORC1 axis coordinates CD8+ T cell activation 286
ASGR1 deficiency diverts lipids toward adipose tissue but results in liver damage during obesity 286
Caloric Restriction Promotes Immunometabolic Reprogramming Leading to Protection from Tuberculosis 284
Gonadal sex vs genetic sex in experimental atherosclerosis 280
Lack of ApoA-I in ApoEKO Mice Causes Skin Xanthomas, Worsening of Inflammation, and Increased Coronary Atherosclerosis in the Absence of Hyperlipidemia 279
Long Pentraxin 3: Experimental and Clinical Relevance in Cardiovascular Diseases 256
Zc3h10 is a novel mitochondrial regulator 251
Comparison of Two Ginkgo biloba L. Extracts on Oxidative Stress and Inflammation Markers in Human Endothelial Cells 251
Fenretinide treatment in apoE-KO mice severely alters erythrocyte turnover and causes a dramatic increase of circulating leukocytes resulting in a worsened atherosclerosis development 251
Purification and in vitro evaluation of an anti-HER2 affibody-2 monomethyl auristatin E conjugate in HER2-positive cancer cells 250
Monocarboxylate transporter 1 deficiency impacts CD8+ T lymphocytes proliferation and recruitment to adipose tissue during obesity 246
Il trattamento con fenretinide peggiora l’aterosclerosi nonostante effetti metabolici favorevoli 240
Pancreatic PCSK9 controls the organization of the β-cell secretory pathway via LDLR-cholesterol axis 235
Neuronal PCSK9 regulates cognitive performances via the modulation of ApoER2 synaptic localization 234
Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation 234
Obesity-Induced Metabolic Stress Leads to Biased Effector Memory CD4+ T Cell Differentiation via PI3K p110δ-Akt-Mediated Signals 230
Genetically determined hypercholesterolaemia results into premature leucocyte telomere length shortening and reduced haematopoietic precursors 224
Rupatadine treatment is associated to atherosclerosis worsening and altered T lymphocyte recruitment 216
Prevention of motor relapses and associated trigeminal pain in experimental autoimmune encephalomyelitis by reducing neuroinflammation with a purple corn extract enriched in anthocyanins 213
Mannose Receptor Deficiency Impacts Bone Marrow and Circulating Immune Cells during High Fat Diet Induced Obesity 201
Fibronectin extra domain a limits liver dysfunction and protects mice during acute inflammation 200
Metabolic reprogramming of naïve regulatory T cells by IL-7 and IL-15 promotes their persistence and performance upon adoptive transfer 187
Rupatadine treatment is associated to atherosclerosis worsening and altered T lymphocytes 187
The Long Pentraxin PTX3: A Biomarker Spanning From Cardiovascular Disorders to Cancer 181
ASGR1 deficiency improves atherosclerosis but alters liver metabolism in ApoE-/- mice 177
Metabolic adaptations of cells at the vascular-immune interface during atherosclerosis 177
Dendritic cell marker Clec4a4 deficiency limits atherosclerosis progression 176
Loss of voltage-gated hydrogen channel 1 expression reveals heterogeneous metabolic adaptation to intracellular acidification by T cells 171
Effect of Lipids and Lipoproteins on Hematopoietic Cell Metabolism and Commitment in Atherosclerosis 169
The Interconnection Between Immuno-Metabolism, Diabetes, and CKD 168
Profiling the impact of anti-human CD20 monoclonal antibodies on lymphocyte B cell subsets and their precursors in the bone marrow and in lymphoid tissues in an immunocompromised mouse engrafted with human cells 167
Role of histone deacetylase 3 (HDAC3) in adipose tissue metabolism and immunophenotype 161
HDL in innate and adaptive immunity 160
HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases 157
Immunometabolic function of cholesterol in cardiovascular disease and beyond 156
Neutral effect of SGLT2 inhibitors on lipoprotein metabolism: From clinical evidence to molecular mechanisms 153
Dendritic cell immunoreceptor 2 (DCIR2) deficiency decreases hepatic conventional dendritic cell content but not the progression of diet-induced obesity 153
Crosstalk between dendritic cells and T lymphocytes during atherogenesis: Focus on antigen presentation and break of tolerance 148
Il trattamento con rupatadina in topi knockout per apolipoproteina e è associato a un peggioramento dell’aterosclerosi e a un alterato reclutamento dei linfociti T 147
Irisin/BDNF pathway dysfunction subserves anorexia nervosa pathophysiology 145
N-glycosylation signature and its relevance in cardiovascular immunometabolism 144
The glucose transporter 2 regulates CD8+ T cell function via environment sensing 136
Lysosomes in the immunometabolic reprogramming of immune cells in atherosclerosis 125
Editorial: Exploiting cellular immunometabolism as a strategy for innovative cardiovascular therapies 114
The heterogeneous cellular landscape of atherosclerosis: Implications for future research and therapies. A collaborative review from the EAS young fellows 96
Cholesterol membrane content has a ubiquitous evolutionary function in immune cell activation : the role of HDL 88
Long-lasting Glucocorticoid and Immune Dysregulation sustain Anorexia Nervosa Beyond Weight Recovery 81
Sleep protects the heart after myocardial infarction through a neuro-immune axis: time to implement healthy sleep for cardiovascular prevention? 80
Irisin-BDNF neurometabolic pathway disruption in the Activity-Based Anorexia model 70
Empowering regulatory T cells to restore immune tolerance and reduce inflammation-driven atherosclerosis 67
Anorexia-induced pheripheral immune dysregulations activate aberrant microglial responses in the hippocampus of adolescent female rats 51
Peripheral and central dysregulation of the immune system in the Activity-Based Anorexia model 51
Activity-based anorexia induces long-lasting peripheral and central dysregulation of the immune response 50
Neuroimmune dysregulation in the activity-based anorexia model 37
Impact of immune system humanization on atherosclerosis in dyslipidemic immunocompromised mice 37
Activity-based anorexia dysregulates the Irisin-BDNF neurometabolic axis in female rats: a muscle-to brain crosstalk 35
The STEROL ELEMENT BINDING PROTEIN 1C (SREBP1c) controls oxidative metabolism and suppressive function of regulatory T cells 27
Dysregulation of the immune response dynamics in a preclinical model of Anorexia Nervosa: evidence of a periphery-to-brain crosstalk 23
Peripheral and central dysregulation of innate and adaptive immunity in anorexia nervosa: evidence from a preclinical model 23
Activity-based anorexia alters innate and adaptive immune response dynamics inducing late microglia activation in the ventral hippocampus of adolescent rats. 19
Immune-metabolic characterization of a humanized mouse model for translational studies on cardiovascular diseases 19
Engineered human CD34+ hematopoietic stem cells as an innovative approach to modulate the immunoinflammatory response during atherosclerosis 19
Immune-metabolic characterization of a humanized mouse model for translational studies on cardiovascular diseases 19
Development of a human immune system experimental model to investigate immune cells activation and targeting for CVD 18
Engineered human CD34+ hematopoietic stem cells as an innovative approach to modulate the immunoinflammatory response during atherosclerosis 16
The STEROL ELEMENT BINDING PROTEIN 1C (SREBP1c) controls oxidative metabolism and suppressive function of regulatory T cells 15
SREBP1c Modulates Treg Immunobiology Through a Phospholipid-Dependent Adenosine Pathway 15
Engineering stem cells for immunomodulatory cell therapy of cardiovascular diseases 14
Engineered human CD34+ hematopoietic stem cells as an innovative approach to modulate the immunoinflammatory response during atherosclerosis 14
Role of STEROL ELEMENT BINDING PROTEIN 1C (SREBP1c) in the metabolism and suppressive function of regulatory T cells 13
Engineering stem cells for immunomodulatory cell therapy of cardiovascular diseases 13
Engineered human CD34+ hematopoietic stem cells as an innovative approach to modulate the immunoinflammatory response during atherosclerosis 12
Engineered human CD34+ hematopoietic stem cells as an innovative approach to modulate the immunoinflammatory response during atherosclerosis 12
Lipopolysaccharide stimulates dynamic changes in B cell metabolism to promote proliferation 9
The STEROL ELEMENT BINDING PROTEIN 1C (SREBP1c) controls oxidative metabolism and suppressive function of regulatory T cells 7
Totale 18.742
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.030
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.205 0 0 0 145 135 106 126 146 221 98 67 161
2022/20231.286 115 113 102 95 133 191 87 104 142 38 98 68
2023/20241.608 96 107 158 167 285 123 65 108 55 117 149 178
2024/20252.781 138 211 116 215 214 168 148 284 185 271 336 495
2025/20266.347 497 469 671 483 475 315 786 244 546 422 861 578
2026/20271.662 386 436 501 339 0 0 0 0 0 0 0 0
Totale 18.742